<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>All participants with pretreatment drug resistance mutations</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Sample</th>
    <th rowspan="2">Age</th>
    <th rowspan="2">Subtype</th>
    <th colspan="3">Targeting drugs of resistant mutations</th>
   </tr>
   <tr>
    <th>NRTIs</th>
    <th>NNRTIs</th>
    <th>PIs</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>076</td>
    <td>58</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>098
     <sup>a</sup>
    </td>
    <td>65</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>132
     <sup>a</sup>
    </td>
    <td>52</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>134
     <sup>a</sup>
    </td>
    <td>56</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>135
     <sup>a</sup>
    </td>
    <td>56</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>322</td>
    <td>71</td>
    <td>01_AE</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>373</td>
    <td>72</td>
    <td>B</td>
    <td/>
    <td>K103 N、K101E</td>
    <td/>
   </tr>
   <tr>
    <td>059</td>
    <td>37</td>
    <td>07_BC</td>
    <td>M184 V</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>063</td>
    <td>47</td>
    <td>01_AE</td>
    <td/>
    <td>K103 N、L100I</td>
    <td/>
   </tr>
   <tr>
    <td>064</td>
    <td>46</td>
    <td>01_AE</td>
    <td/>
    <td>K103 N、L100I</td>
    <td/>
   </tr>
   <tr>
    <td>166</td>
    <td>43</td>
    <td>07_BC</td>
    <td>K219 N</td>
    <td>Y181C</td>
    <td/>
   </tr>
   <tr>
    <td>173</td>
    <td>43</td>
    <td>01_AE</td>
    <td/>
    <td/>
    <td>M46 L</td>
   </tr>
   <tr>
    <td>231
     <sup>a</sup>
    </td>
    <td>48</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>263</td>
    <td>46</td>
    <td>B</td>
    <td/>
    <td>K103 N</td>
    <td/>
   </tr>
   <tr>
    <td>343</td>
    <td>36</td>
    <td>07_BC</td>
    <td/>
    <td>V106 M</td>
    <td/>
   </tr>
   <tr>
    <td>345</td>
    <td>34</td>
    <td>08_BC</td>
    <td/>
    <td>G190A</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>PI</italic> protease inhibitors, 
   <italic>NRTI</italic> nucleoside reverse transcriptase inhibitors, 
   <italic>NNRTI</italic> non-nucleoside reverse transcriptase inhibitors; “
   <sup>a</sup>”, sequences in local transmission clusters
  </p>
 </table-wrap-foot>
</table-wrap>
